Categories: News

CONMED Corporation to Present at the Bank of America Merrill Lynch Healthcare Conference

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

UTICA, N.Y.–(BUSINESS WIRE)–CONMED Corporation (NASDAQ: CNMD) today announced that Todd W.
Garner, Executive Vice President and Chief Financial Officer, will
present at the Bank of America Merrill Lynch Healthcare Conference at
10:40 a.m. PT on Thursday, May 16, 2019 in Las Vegas, NV.

A live webcast of the presentation will be accessible through the
“Investors” section of the Company’s website at www.conmed.com
and will be available for replay following the event.

About CONMED Corporation

CONMED is a medical technology company that provides surgical devices
and equipment for minimally invasive procedures. The Company’s products
are used by surgeons and physicians in a variety of specialties,
including orthopedics, general surgery, gynecology, neurosurgery,
thoracic surgery and gastroenterology. For more information, visit www.conmed.com.

Forward-Looking Statements

This press release may contain forward-looking statements based on
certain assumptions and contingencies that involve risks and
uncertainties, which could cause actual results, performance, or trends
to differ materially from those expressed in the forward-looking
statements herein or in previous disclosures. For example, in addition
to general industry and economic conditions, factors that could cause
actual results to differ materially from those in the forward-looking
statements may include, but are not limited to, the risk factors
discussed in the Company’s Annual Report on Form 10-K for the fiscal
year ended December 31, 2018 and listed under the heading Forward-Looking
Statements
in the Company’s most recently filed Form 10-Q. Any and
all forward-looking statements are made pursuant to the safe harbor
provisions of the Private Securities Litigation Reform Act of 1995 and
relate to the Company’s performance on a going-forward basis. The
Company believes that all forward-looking statements made by it have a
reasonable basis, but there can be no assurance that management’s
expectations, beliefs or projections as expressed in the forward-looking
statements will actually occur or prove to be correct.

Contacts

CONMED Corporation
Todd W. Garner
Chief
Financial Officer

315-624-3317
ToddGarner@conmed.com

Staff

Recent Posts

REACH Trial Evaluating First-Line Treatment of Refractory Chronic Cough Completes Enrollment

Top-line data anticipated in early Q3 2025. BOSTON--(BUSINESS WIRE)--Sensory Cloud Inc., a health technology company…

23 minutes ago

REACH Trial Evaluating First-Line Treatment of Refractory Chronic Cough Completes Enrollment

Top-line data anticipated in early Q3 2025. BOSTON--(BUSINESS WIRE)--Sensory Cloud Inc., a health technology company…

25 minutes ago

o9 to Host aim10x Europe 2025 in Amsterdam on June 3

The Summit will bring together supply chain, commercial, finance, IT, and procurement leaders to explore…

26 minutes ago

Progyny Appoints Two Renowned Women’s Health Experts to Medical Advisory Board

Medical Advisory Board additions support company’s growing product offerings across women’s health and family building…

27 minutes ago

Outset Medical Appoints Industry Veteran Kevin O’Boyle to its Board of Directors

SAN JOSE, Calif., May 14, 2025 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”),…

27 minutes ago